These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21247167)

  • 21. Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
    Childress ES; Wieting JM; Felts AS; Breiner MM; Long MF; Luscombe VB; Rodriguez AL; Cho HP; Blobaum AL; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
    J Med Chem; 2019 Jan; 62(1):378-384. PubMed ID: 30350962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-operative binding assay for the characterization of mGlu4 allosteric modulators.
    Poutiainen P; Kil KE; Zhang Z; Kuruppu D; Tannous B; Brownell AL
    Neuropharmacology; 2015 Oct; 97():142-8. PubMed ID: 26025660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold.
    Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors.
    Hemstapat K; Da Costa H; Nong Y; Brady AE; Luo Q; Niswender CM; Tamagnan GD; Conn PJ
    J Pharmacol Exp Ther; 2007 Jul; 322(1):254-64. PubMed ID: 17416742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead.
    Williams R; Niswender CM; Luo Q; Le U; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):962-6. PubMed ID: 19097893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveying heterocycles as amide bioisosteres within a series of mGlu
    Reed CW; Washecheck JP; Quitlag MC; Jenkins MT; Rodriguez AL; Engers DW; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW
    Bioorg Med Chem Lett; 2019 May; 29(10):1211-1214. PubMed ID: 30910459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.
    Ullmer C; Zoffmann S; Bohrmann B; Matile H; Lindemann L; Flor P; Malherbe P
    Br J Pharmacol; 2012 Dec; 167(7):1448-66. PubMed ID: 22747985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
    Wenthur CJ; Morrison RD; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2693-8. PubMed ID: 24794112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.
    Gregory KJ; Conn PJ
    Mol Pharmacol; 2015 Jul; 88(1):188-202. PubMed ID: 25808929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-exploring the N-phenylpicolinamide derivatives to develop mGlu4 ligands with improved affinity and in vitro microsomal stability.
    Zhang Z; Kil KE; Poutiainen P; Choi JK; Kang HJ; Huang XP; Roth BL; Brownell AL
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3956-60. PubMed ID: 26231155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.
    Felts AS; Rodriguez AL; Smith KA; Engers JL; Morrison RD; Byers FW; Blobaum AL; Locuson CW; Chang S; Venable DF; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Emmitte KA
    J Med Chem; 2015 Nov; 58(22):9027-40. PubMed ID: 26524606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurobiological Insights from mGlu Receptor Allosteric Modulation.
    O'Brien DE; Conn PJ
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26647381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
    Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).
    Engers DW; Niswender CM; Weaver CD; Jadhav S; Menon UN; Zamorano R; Conn PJ; Lindsley CW; Hopkins CR
    J Med Chem; 2009 Jul; 52(14):4115-8. PubMed ID: 19469556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiological insights and novel therapeutic opportunities for CNS disorders from mGlu receptor allosteric and biased modulation.
    Hellyer S; Leach K; Gregory KJ
    Curr Opin Pharmacol; 2017 Feb; 32():49-55. PubMed ID: 27842256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR.
    Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.
    Ahnaou A; Dautzenberg FM; Geys H; Imogai H; Gibelin A; Moechars D; Steckler T; Drinkenburg WH
    Eur J Pharmacol; 2009 Jan; 603(1-3):62-72. PubMed ID: 19046965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
    Lesage A; Steckler T
    Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Varnes JG; Marcus AP; Mauger RC; Throner SR; Hoesch V; King MM; Wang X; Sygowski LA; Spear N; Gadient R; Brown DG; Campbell JB
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1402-6. PubMed ID: 21295468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.